跳至主要内容
临床试验/NCT03607591
NCT03607591已完成不适用

Efficacy of High Frequency (15Hz) Repetitive Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex in Decreasing Intake in Patients With Cocaine Use Disorder: Study Protocol for a Randomized Placebo Controlled Trial

Azienda Ospedaliero-Universitaria Careggi2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2018年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
65
试验地点
2
主要终点
Cocaine intake

研究概览

简要总结

The study evaluates the efficacy of 3 weeks of repetitive transcranial magnetic stimulation (rTMS), 5 sessions/weekly, in reducing cocaine consumption immediately after and within the 8 weeks following the treatment in addicted patients with cocaine use disorders (CUD) versus placebo.

详细描述

40 patients are expected and randomized in two groups: 20 patients with active rTMS and 20 with placebo rTMS.

Visit 1: 15 days (3 weeks of 5 consecutive daily sessions and 2 days of rest) 15Hz rTMS is performed during the following days in addition to a biweekly urine drug test and VAS evaluation.

Visit 2: Changes from baseline to week 8 in cocaine intake. Evaluation of craving and of other assessments like mood and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male and female patients between 18 and 65 years of age
  • patients who meet the criteria for CUD reported in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V)
  • positivity to cocaine use, determined via an urine drug test
  • patients who are able to provide a written informed consent, after being notified about the treatment and the study protocol

排除标准

  • major depression disorder, schizophrenia, bipolar disorder or other psychosis that meet the diagnostic criteria of the DSM-V
  • illiteracy or cognitive impairment disorders
  • women who are pregnant or lactating
  • other medical diseases that contraindicate rTMS treatment such as epilepsy
  • presence of devices, i.e. pace-makers or cochlear prosthesis
  • previous rTMS treatments in order to avoid confounding factors
  • patients who can not provide the written informed consent
  • DSM-V substance use disorders other than CUD. Only tobacco smoke is allowed to be recruited in the study protocol.

结局指标

主要结局

Cocaine intake

时间窗: 8 weeks following the treatment

Baseline was defined as cocaine consumption before randomization (visit 0). Baseline will be determined using an urine drug test.Changes from baseline to week 8 in cocaine intake

次要结局

  • Craving first measure(8 weeks following the treatment)
  • Craving second measure(8 weeks following the treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Antonello Grippo

Medical Doctor

Azienda Ospedaliero-Universitaria Careggi

研究点 (2)

Loading locations...

相似试验

Efficacy of Repetitive Transcranial Magnetic... | 临床试验